Back to AG Adage Capital Partners GP, L.L.C.
ARWR
Showing 4 of 26 quarters
Position history for AGAdage Capital Partners GP, L.L.C.'s holdings in Arrowhead Pharmaceuticals, Inc.
No. Adage Capital Partners GP exited its ARWR (Arrowhead Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 550,000 shares worth $36.5M. Adage Capital Partners GP already held ARWR in its Q4 2018 13F, the earliest on record, and held it in 23 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6.8M
Total Shares Change
-350,000
Quarter-by-Quarter History